Keros Therapeutics, Inc.
KROS | US
Overview
Corporate Details
- ISIN(s):
- US4923271013
- LEI:
- Country:
- United States of America
- Address:
- 1050 WALTHAM STREET, SUITE 302, 2421 LEXINGTON
- Website:
- https://www.kerostx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Keros Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Keros Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Keros Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel
EVGN
Israel
EVGN
Germany
EVT
Develops nucleic acid therapies via its SNA™ platform for neurology, oncology, & genetic diseases.
United States of America
XCUR
United States of America
XCUR
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
South Korea
185490
South Korea
185490
Non-viral cell engineering platform for rapid, cost-effective cell and gene therapy development.
South Korea
327610
South Korea
327610
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden
FLUI
Sweden
FLUI
Pioneering medicines targeting the chromatin regulatory system to treat genetically defined cancers.
United States of America
FHTX
United States of America
FHTX
Global CRO managing clinical trials for the biopharmaceutical and medical device industries.
United States of America
FTRE
United States of America
FTRE
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom
FAB
United Kingdom
FAB